内甲素-1的动力学和对选择性ETA对抗作用对ETB激活:一个数学建模分析
K Melissa Hallow1,2, Peter J Greasley3, Hiddo J L Heerspink4,5
1School of Chemical, Materials, and Biomedical Engineering, University of Georgia, Athens, GA, United States.
Frontiers in pharmacology
|December 12, 2024
概括
选择性ETA受体对手可以通过影响ET-1与ETB受体的结合来引起液体保留. 这项研究开发了一个数学模型来预测这些效应,揭示了影响ET-1度和受体结合的复杂相互作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生理学 生理学 生理学
- 数学建模的数学建模
背景情况:
- 内甲素-1 (ET-1) 对于和血管功能至关重要.
- 选择性ETA受体对抗剂受到液体保留的限制,其机制尚不清楚.
- 与ETB受体结合的ET-1可能是液体保留的基础.
研究的目的:
- 开发ET-1运动的数学模型.
- 量化ETA对抗剂暴露和选择性对ET-1及其受体复合物的影响.
- 阐明ETB受体相互作用在ET-1调节中的作用.
主要方法:
- 开发了一种ET-1运动的机械数学模型.
- 模拟ET-1的产生,分布和受体结合 (ETA和ETB).
- 使用人类ET-1输液研究校准和验证模型.
主要成果:
- 该模型证实了ETB在ET-1清除中的重要作用.
- 模拟显示选择性的ETA对手降低[ET1-ETA].
- ETB复合物度 ([ET1-ETB) 随着药物度接近Kia而增加,但在较高度下降,选择性较低的对抗剂的值较低.
结论:
- 这是首个结合受体介导清除的ET-1动态的机械数学模型.
- 该模型量化了ETB封锁对ET-1度的影响.
- 该模型作为研究ET-1动态和受体相互作用的工具.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
135
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
135
Antihypertensive Drugs: Angiotensin II Receptor Blockers
581
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
581
Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
477
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
477
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Antihypertensive Drugs: Action of β1 Blockers
307
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
307


